KIMBERLY NOVAK: Open Payments
NPI 1184346793 · SHOW LOW, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 36 payments from 12 companies in 2025. Trend: 2023 $399 · 2024 $478 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $195 |
| Novo Nordisk Inc | 5 | $103 |
| PFIZER INC. | 6 | $96 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Exact Sciences Corporation | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Astellas Pharma US Inc | 3 | $47 |
| Grifols USA, LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: FASENRA, GEMTESA, Cologuard Collection Kit, ELIQUIS, BREZTRI, PREVNAR 20, Veozah, Wegovy.
Industry payments across AZ — which companies pay providers there.
